BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

CSL Behring 

1020 First Avenue
P.O. Box 61501
King of Prussia  Pennsylvania  19406-0901  U.S.A.
Phone: 610-878-4000 Fax: 610-878-4009


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology






 Company News
CSL Behring Awards Young Researchers Around The World To Advance Coagulation Science 4/24/2015 12:25:25 PM
CSL Behring Marks World Hemophilia Day By Renewing Pledge To World Federation Of Hemophilia 4/14/2015 11:12:54 AM
European Medicines Agency Commences Review Of CSL Behring's Regulatory Submission For Rix-FP For Hemophilia B Patients 3/30/2015 12:50:45 PM
The Lancet Publishes CSL Behring's Kcentra Phase III Data 3/17/2015 7:25:40 AM
CSL Behring To Provide $80,000 In Scholarship Funding For Low-Income Students In Philadelphia Area 3/9/2015 10:36:44 AM
CSL Behring Continues Treatment Access Leadership By Donating Bleeding Disorder Protein Therapies IUs To World Federation Of Hemophilia 2/27/2015 10:31:03 AM
U.S. FDA Accepts For Review CSL Behring's Biologics License Application For rIX-FP For Hemophilia B Patients 2/4/2015 11:11:40 AM
Snag a Job: Here's How CSL Behring Makes Hiring Decisions 2/3/2015 4:51:41 PM
FDA Approves New Dosing Option for CSL Behring's Hizentra® 2/2/2015 9:20:36 AM
CSL Behring Submits Biologics License Application For FDA Approval Of Recombinant Fusion Protein Linking Coagulation Factor IX With Recombinant Albumin (Rix-FP) For Hemophilia B Patients 12/16/2014 8:36:38 AM
12345678910...